{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:30:53Z","timestamp":1790656253698,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":139,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Notes"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.biotno.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T19:15:38Z","timestamp":1653506138000},"page":"32-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Hyperuricemia and the small intestine: Transport mechanisms and co-morbidities"],"prefix":"10.1016","volume":"3","author":[{"given":"Yanbo","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4620-4688","authenticated-orcid":false,"given":"John","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biotno.2022.05.001_bib1","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.2174\/1381612811319130011","article-title":"Chronic hyperuricemia, uric acid deposit and cardiovascular risk","volume":"19","author":"Grassi","year":"2013","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.biotno.2022.05.001_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","article-title":"Physiological functions and pathogenic potential of uric acid: a review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J Adv Res"},{"key":"10.1016\/j.biotno.2022.05.001_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2018.00160","article-title":"Physiology of hyperuricemia and urate-lowering treatments","volume":"5","author":"Benn","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.biotno.2022.05.001_bib4","doi-asserted-by":"crossref","unstructured":"Pascual, E. & Andres, M. in Gout 78\u201394 (2013).","DOI":"10.2217\/ebo.12.222"},{"key":"10.1016\/j.biotno.2022.05.001_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12325-014-0175-z","article-title":"A review of uric acid, crystal deposition disease, and gout","volume":"32","author":"Perez-Ruiz","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.biotno.2022.05.001_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bdd.1909","article-title":"SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria","volume":"35","author":"Chino","year":"2014","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.biotno.2022.05.001_bib7","doi-asserted-by":"crossref","first-page":"16229","DOI":"10.1074\/jbc.M312226200","article-title":"Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking","volume":"279","author":"Augustin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biotno.2022.05.001_bib8","doi-asserted-by":"crossref","first-page":"E831","DOI":"10.1152\/ajpendo.00296.2009","article-title":"Facilitative glucose transporter 9, a unique hexose and urate transporter","volume":"297","author":"Doblado","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.biotno.2022.05.001_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fphys.2018.00476","article-title":"Human mutations in SLC2A9 (Glut9) affect transport capacity for urate","volume":"9","author":"Ruiz","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.biotno.2022.05.001_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MNH.0b013e328363ffc8","article-title":"Urate transporters in the genomic era","volume":"22","author":"Sakurai","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.biotno.2022.05.001_bib11","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/15257770.2011.628354","article-title":"Increased expression of SLC2A9 decreases urate excretion from the kidney","volume":"30","author":"Kimura","year":"2011","journal-title":"Nucleos Nucleot Nucleic Acids"},{"key":"10.1016\/j.biotno.2022.05.001_bib12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/15257770.2011.623685","article-title":"Pathogenic GLUT9 mutations causing renal hypouricemia type 2 (RHUC2)","volume":"30","author":"Kawamura","year":"2011","journal-title":"Nucleos Nucleot Nucleic Acids"},{"key":"10.1016\/j.biotno.2022.05.001_bib13","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1038\/ncomms5642","article-title":"Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9","volume":"5","author":"DeBosch","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.biotno.2022.05.001_bib14","first-page":"173","article-title":"Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritis","volume":"15","author":"Ristic","year":"2020","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.biotno.2022.05.001_bib15","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1038\/s41598-018-21425-7","article-title":"ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.biotno.2022.05.001_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/15257770.2013.854902","article-title":"ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion","volume":"33","author":"Takada","year":"2014","journal-title":"Nucleos Nucleot Nucleic Acids"},{"key":"10.1016\/j.biotno.2022.05.001_bib17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.biotno.2022.05.001_bib18","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/srep02014","article-title":"Common dysfunctional variants in ABCG2 are a major cause of early-onset gout","volume":"3","author":"Matsuo","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.biotno.2022.05.001_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030456","article-title":"Extra-renal elimination of uric acid via intestinal efflux transporter BCRP\/ABCG2","volume":"7","author":"Hosomi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biotno.2022.05.001_bib22","doi-asserted-by":"crossref","first-page":"43614","DOI":"10.1038\/srep43614","article-title":"Effects of multiple genetic loci on the pathogenesis from serum urate to gout","volume":"7","author":"Dong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.biotno.2022.05.001_bib23","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood-2008-03-147850","article-title":"A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration","volume":"112","author":"van de Ven","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biotno.2022.05.001_bib24","doi-asserted-by":"crossref","first-page":"F1327","DOI":"10.1152\/ajprenal.00680.2010","article-title":"Avian renal proximal tubule urate secretion is inhibited by cellular stress-induced AMP-activated protein kinase","volume":"300","author":"Bataille","year":"2011","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.biotno.2022.05.001_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12917-019-1886-9","article-title":"Uric acid transporters BCRP and MRP4 involved in chickens uric acid excretion","volume":"15","author":"Ding","year":"2019","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.biotno.2022.05.001_bib26","first-page":"1","article-title":"American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.biotno.2022.05.001_bib27","first-page":"S41","article-title":"Clinical manifestations of patients with hyperuricemia","volume":"87","author":"Akkasilpa","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.biotno.2022.05.001_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"Richette","year":"2010","journal-title":"Gout. Lancet"},{"key":"10.1016\/j.biotno.2022.05.001_bib29","first-page":"60","article-title":"Synovial fluid uric acid level aids diagnosis of gout","volume":"9","author":"Vaidya","year":"2018","journal-title":"Biomed Rep"},{"key":"10.1016\/j.biotno.2022.05.001_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout","volume":"131","author":"Pascual","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biotno.2022.05.001_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3476(96)70322-0","article-title":"Abnormal serum uric acid levels in children","volume":"128","author":"Wilcox","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.biotno.2022.05.001_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.biotno.2022.05.001_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-018-1596-x","article-title":"Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy","volume":"20","author":"Drivelegka","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.biotno.2022.05.001_bib34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1507\/endocrj.EJ13-0203","article-title":"Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder","volume":"60","author":"Kurahashi","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.biotno.2022.05.001_bib35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12958-018-0419-x","article-title":"Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome","volume":"16","author":"Mu","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.biotno.2022.05.001_bib36","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/dc09-0288","article-title":"Association between serum uric acid and development of type 2 diabetes","volume":"32","author":"Kodama","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biotno.2022.05.001_bib37","article-title":"High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies","volume":"8","author":"Lv","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biotno.2022.05.001_bib38","first-page":"81","article-title":"Elevation of serum uric acid and incidence of type 2 diabetes: a systematic review and meta-analysis","volume":"2","author":"Xu","year":"2016","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.biotno.2022.05.001_bib39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/qjmed\/hct093","article-title":"Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout","volume":"106","author":"Krishnan","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.biotno.2022.05.001_bib40","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/aje\/kwt320","article-title":"Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population","volume":"179","author":"Juraschek","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biotno.2022.05.001_bib41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjmed.2010.03.027","article-title":"Serum uric acid levels and the risk of type 2 diabetes: a prospective study","volume":"123","author":"Bhole","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.biotno.2022.05.001_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000834","article-title":"Mendelian randomization study of serum uric acid levels and diabetes risk: evidence from the Dongfeng-Tongji cohort","volume":"8","author":"Keerman","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.biotno.2022.05.001_bib43","first-page":"459","article-title":"Serum uric acid levels in type 2 diabetes mellitus","volume":"7","author":"Modi","year":"2018","journal-title":"Indian J Basic Appl Med Res"},{"key":"10.1016\/j.biotno.2022.05.001_bib44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.diabres.2008.01.002","article-title":"Serum uric acid and incident diabetes in Mauritian Indian and Creole populations","volume":"80","author":"Nan","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.biotno.2022.05.001_bib45","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1210\/jc.2016-2107","article-title":"High normal uric acid levels are associated with an increased risk of diabetes in lean, normoglycemic healthy women","volume":"101","author":"Shani","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.biotno.2022.05.001_bib46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM196609012750902","article-title":"Hyperuricemia in primary and renal hypertension","volume":"275","author":"Cannon","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biotno.2022.05.001_bib47","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1542\/peds.2013-0047","article-title":"Serum uric acid and blood pressure in children at cardiovascular risk","volume":"132","author":"Viazzi","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.biotno.2022.05.001_bib48","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/ajh\/hpaa030","article-title":"Impact of uric acid on hypertension occurrence and target organ damage: insights from the STANISLAS cohort with a 20-year follow-up","volume":"33","author":"Kanbay","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.biotno.2022.05.001_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/HYPERTENSIONAHA.117.10370","article-title":"Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study","volume":"71","author":"Kuwabara","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.biotno.2022.05.001_bib50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jash.2015.05.010","article-title":"Uric acid levels within the normal range predict increased risk of hypertension: a cohort study","volume":"9","author":"Leiba","year":"2015","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.biotno.2022.05.001_bib51","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/clc.23266","article-title":"The association between hyperuricemia and coronary artery calcification development: a systematic review and meta-analysis","volume":"42","author":"Liang","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.biotno.2022.05.001_bib52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2016.09.035","article-title":"Dose-response relationship between serum uric acid levels and risk of incident coronary heart disease in the Dongfeng-Tongji Cohort","volume":"224","author":"Lai","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.biotno.2022.05.001_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11302-018-9604-9","article-title":"Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome","volume":"14","author":"Gaubert","year":"2018","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.biotno.2022.05.001_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2017.04.027","article-title":"Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome","volume":"240","author":"Magnoni","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.biotno.2022.05.001_bib55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.biotno.2022.05.001_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","article-title":"Uric acid and risk of heart failure: a systematic review and meta-analysis","volume":"16","author":"Huang","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.biotno.2022.05.001_bib57","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCHEARTFAILURE.108.797662","article-title":"Hyperuricemia and incident heart failure","volume":"2","author":"Krishnan","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.biotno.2022.05.001_bib58","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2217\/bmm.10.94","article-title":"Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis","volume":"4","author":"Cipriani","year":"2010","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.biotno.2022.05.001_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/aje\/kwm127","article-title":"Plasma urate and risk of Parkinson's disease","volume":"166","author":"Weisskopf","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biotno.2022.05.001_bib60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamaneurol.2013.5528","article-title":"Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial","volume":"71","author":"Parkinson Study Group","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biotno.2022.05.001_bib61","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/archneur.2008.65.6.nct70003","article-title":"Serum urate as a predictor of clinical and radiographic progression in Parkinson disease","volume":"65","author":"Schwarzschild","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biotno.2022.05.001_bib62","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/annrheumdis-2014-206917","article-title":"Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study","volume":"75","author":"Lu","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.biotno.2022.05.001_bib63","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1096\/fj.05-5223com","article-title":"Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms","volume":"20","author":"Zhang","year":"2006","journal-title":"Faseb J"},{"key":"10.1016\/j.biotno.2022.05.001_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086651","article-title":"The neutron structure of urate oxidase resolves a long-standing mechanistic conundrum and reveals unexpected changes in protonation","volume":"9","author":"Oksanen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biotno.2022.05.001_bib65","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.22403","article-title":"Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout","volume":"56","author":"Sundy","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.biotno.2022.05.001_bib66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ddr.20493","article-title":"Uricases as therapeutic agents to treat refractory gout: current states and future directions","volume":"73","author":"Yang","year":"2012","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.biotno.2022.05.001_bib67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.20781","article-title":"Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis A randomized clinical trial","volume":"52","author":"Garg","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Biotechnology Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665906922000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665906922000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:16:29Z","timestamp":1762938989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665906922000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":65,"alternative-id":["S2665906922000034"],"URL":"https:\/\/doi.org\/10.1016\/j.biotno.2022.05.001","relation":{},"ISSN":["2665-9069"],"issn-type":[{"value":"2665-9069","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperuricemia and the small intestine: Transport mechanisms and co-morbidities","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Notes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotno.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}